Literature DB >> 1314221

Inactivation of human serum bactericidal activity by a trypsinlike protease isolated from Porphyromonas gingivalis.

D Grenier1.   

Abstract

A protease was isolated from an outer membrane vesicle preparation of Porphyromonas gingivalis ATCC 33277 and assessed for its ability to inactivate the bactericidal activity of normal human serum. The enzyme, which was activated by reducing agents, was found to be a trypsinlike protease with a molecular mass of approximately 80 kDa. Prior to being tested in the bactericidal assay, pooled human serum was preincubated with the partially purified enzyme. Under conditions in which the trypsinlike protease was activated, a strong reduction of the serum bactericidal activity against Capnocytophaga ochracea was noted. On the other hand, no reduction of the bactericidal action of serum was observed when the serum-protease mixture was preincubated in the presence of an inhibitor of the enzyme. As determined by sodium dodecyl sulfate-polyacrylamide gel electrophoresis, the protease was shown to degrade immunoglobulins G and M as well as complement factor C3. This study confirms the previous hypothesis that the proteases of P. gingivalis can interfere with the protective action of human serum.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1314221      PMCID: PMC257084          DOI: 10.1128/iai.60.5.1854-1857.1992

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  28 in total

1.  Generation and degradation of the complement fragment C5a in human serum by Bacteroides gingivalis.

Authors:  G Sundqvist; A Bengtson; J Carlsson
Journal:  Oral Microbiol Immunol       Date:  1988-09

Review 2.  Nature of periodontal diseases: assessment and diagnosis.

Authors:  K S Kornman
Journal:  J Periodontal Res       Date:  1987-05       Impact factor: 4.419

3.  Degradation of albumin, haemopexin, haptoglobin and transferrin, by black-pigmented Bacteroides species.

Authors:  J Carlsson; J F Höfling; G K Sundqvist
Journal:  J Med Microbiol       Date:  1984-08       Impact factor: 2.472

4.  Isolation of a membrane-associated Bacteroides gingivalis glycylprolyl protease.

Authors:  D Grenier; B C McBride
Journal:  Infect Immun       Date:  1987-12       Impact factor: 3.441

5.  Development of a diagnostic test for anaerobic periodontal infections based on plaque hydrolysis of benzoyl-DL-arginine-naphthylamide.

Authors:  W J Loesche; W A Bretz; D Kerschensteiner; J Stoll; S S Socransky; P Hujoel; D E Lopatin
Journal:  J Clin Microbiol       Date:  1990-07       Impact factor: 5.948

6.  Bacteroides gingivalis vesicles mediate attachment of streptococci to serum-coated hydroxyapatite.

Authors:  U Singh; D Grenier; B C McBride
Journal:  Oral Microbiol Immunol       Date:  1989-12

7.  Isolation and characterization of a protease from Bacteroides gingivalis.

Authors:  S Fujimura; T Nakamura
Journal:  Infect Immun       Date:  1987-03       Impact factor: 3.441

8.  An in vitro model to study bacterial invasion of periodontal tissues.

Authors:  J R Winkler; V Matarese; C I Hoover; R H Kramer; P A Murray
Journal:  J Periodontol       Date:  1988-01       Impact factor: 6.993

9.  Further studies on the degradation of immunoglobulins by black-pigmented Bacteroides.

Authors:  D Grenier; D Mayrand; B C McBride
Journal:  Oral Microbiol Immunol       Date:  1989-03

10.  Heterogeneity of virulence among strains of Bacteroides gingivalis.

Authors:  M E Neiders; P B Chen; H Suido; H S Reynolds; J J Zambon; M Shlossman; R J Genco
Journal:  J Periodontal Res       Date:  1989-05       Impact factor: 4.419

View more
  21 in total

1.  A metalloproteinase karilysin present in the majority of Tannerella forsythia isolates inhibits all pathways of the complement system.

Authors:  Monika Jusko; Jan Potempa; Abdulkarim Y Karim; Miroslaw Ksiazek; Kristian Riesbeck; Peter Garred; Sigrun Eick; Anna M Blom
Journal:  J Immunol       Date:  2012-01-27       Impact factor: 5.422

2.  A functional virulence complex composed of gingipains, adhesins, and lipopolysaccharide shows high affinity to host cells and matrix proteins and escapes recognition by host immune systems.

Authors:  Ryosuke Takii; Tomoko Kadowaki; Atsuyo Baba; Takayuki Tsukuba; Kenji Yamamoto
Journal:  Infect Immun       Date:  2005-02       Impact factor: 3.441

Review 3.  Toll gates to periodontal host modulation and vaccine therapy.

Authors:  George Hajishengallis
Journal:  Periodontol 2000       Date:  2009       Impact factor: 7.589

Review 4.  Virulence and immunomodulatory roles of bacterial outer membrane vesicles.

Authors:  Terri N Ellis; Meta J Kuehn
Journal:  Microbiol Mol Biol Rev       Date:  2010-03       Impact factor: 11.056

Review 5.  Complement-related proteins in pathogenic organisms.

Authors:  Z Fishelson
Journal:  Springer Semin Immunopathol       Date:  1994

6.  Functional properties of nonhuman primate antibody to Porphyromonas gingivalis.

Authors:  D M Anderson; J L Ebersole; M J Novak
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

7.  Analysis of human immunoglobulin-degrading cysteine proteinases of Trichomonas vaginalis.

Authors:  D Provenzano; J F Alderete
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

8.  Cysteine protease of Porphyromonas gingivalis 381 enhances binding of fimbriae to cultured human fibroblasts and matrix proteins.

Authors:  M Kontani; H Ono; H Shibata; Y Okamura; T Tanaka; T Fujiwara; S Kimura; S Hamada
Journal:  Infect Immun       Date:  1996-03       Impact factor: 3.441

9.  The multiple forms of trypsin-like activity present in various strains of Porphyromonas gingivalis are due to the presence of either Arg-gingipain or Lys-gingipain.

Authors:  J Potempa; R Pike; J Travis
Journal:  Infect Immun       Date:  1995-04       Impact factor: 3.441

10.  Effect of inactivation of the Arg- and/or Lys-gingipain gene on selected virulence and physiological properties of Porphyromonas gingivalis.

Authors:  Daniel Grenier; Sophie Roy; Fatiha Chandad; Pascale Plamondon; Masami Yoshioka; Koji Nakayama; Denis Mayrand
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.